TAG:
pathology service associates
AmeriPath Pursues Ambitious Strategy Of Rapid Expansion
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
CEO SUMMARY: As the pathology profession’s only publicly-traded physician practice management company, AmeriPath is the spear point of far-reaching changes now transforming pathology. With an annual revenue run rate of $270 million and an ample war chest of growth capital, AmeriPath int…
Single-Specialty Path PPMs Posting Strong Growth, Profits
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Although the financial travails of the physician practice management (PPM) industry are widely known, there is little recognition that a number of single-specialty PPMs are doing well. This is true of pathology, where at least six pathology-based PPMs still remain in business…
Pathology Profession Facing New Directions
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
CEO SUMMARY: Big changes ahead during the next decade. Among the predictions: the number of two and three-pathologist group practices will radically diminish; pathology centers of excellence will achieve new market dominance; and…ever more intense competition for anatomic pathology spec…
“October 11, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
Here’s a hats-off to Ortho-Clinical Diagnostics (OCD). At a time when everything in the healthcare system seems to be taking things away from clinical laboratories, OCD has organized a worthwhile laboratory management best practices day for its most loyal customers. Started four ye…
“August 30, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 12 – August 30, 1999 Issue
There’s a new for-profit hospital player out there which probably needs a good laboratory leader. Iasis Corp. of Nashville, Tennessee just spent more than $800 million to buy 15 hospitals. Iasis is a hospital management company. It expects both deals to close in October. Odds are t…
DIANON Systems Nails Contract To Provide AP Services To Aetna
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
Sand sales efforts paid off for DIANON Systems, Inc. of Stratford, Connecticut. Last month the publicly-traded lab disclosed a new contract with Aetna/U.S. Healthcare. The pact, signed with Aetna and SmithKline Beecham Clinical Laboratories (SBCL), …
Labs Entering New Cycle Of Evolution and Change
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: As some of the nation’s most astute and forward-looking lab executives prepare to gather in New Orleans for the fourth annual EXECUTIVE WAR COLLEGE, it is time to share our assessment of the laboratory and pathology industry. Recent events presage another profound …
Movers & Shakers For ’99 Demonstrate Leadership
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple. Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of…
DIANON Wins Contract, Buys Kyto Meridien Lab
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY:Anatomic pathology took another forward step on the managed care battleground. DIANON Systems, Inc. gained status as a provider of anatomic pathology services under the new master agreement announced by Oxford Health Plans. DIANON’s success demonstrates that anatomic patholo…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out” of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized